[Effect of administration of blood products on the course of tetanus antibody concentration in immuno-incompetent patients].
Collecting of data for immunoprophylaxis of tetanus in immunodeficient patients via administration of blood products. Prospective single case studies. Clinical therapy in a department of hematology with continuous determination of tetanus antibody concentrations in patients' sera and administered blood products with an enzyme immunoassay. 3 patients with acute myeloid leukemia (FAB classifications M1, M3, M4). Regular administration of blood products due to clinical therapy. After administration of about 4,000 IU tetanus antitoxin i.v., serum concentration is increasing by 1 IU/ml. Half life in serum amounts to 7 days. Protection lasts therefore up to 6 weeks. Immunodeficient patients may receive a medium-term effective protection against tetanus after selection of suitable blood products. This method is interesting also for prophylaxis of postoperative tetanus in immunocompetent patients.